Research Overview: Atarax
Atarax 25mg is a pharmaceutical-grade antihistamine formulation containing hydroxyzine hydrochloride manufactured by Dr. Reddy’s Laboratories. Hydroxyzine HCl is a first-generation antihistamine and anxiolytic compound that belongs to the piperazine class of medications. This established pharmaceutical preparation provides researchers with standardised hydroxyzine dosing for investigating antihistaminic mechanisms, anxiolytic pathways, and sedative properties in controlled laboratory environments. The compound demonstrates dual pharmacological activity through H1-receptor antagonism and central nervous system modulation, making it valuable for diverse research applications in neuropharmacology and immunology studies.
Laboratory Applications
Research teams investigate hydroxyzine’s antihistaminic properties in allergic response models, examining its competitive antagonism at peripheral H1-receptors. The compound’s anxiolytic mechanisms are studied through its effects on GABAergic neurotransmission and serotonergic pathways in neural tissue preparations. Hydroxyzine research extends to sleep studies, where investigators analyse its sedative properties and effects on sleep architecture in laboratory models. Comparative pharmacology studies utilise this compound to evaluate antihistamine selectivity, anticholinergic activity, and central versus peripheral nervous system penetration. Researchers at Stroid UK Shop source authentic pharmaceutical preparations for comprehensive antihistamine investigations. The standardised tablet formulation ensures consistent dosing for reproducible research outcomes across different experimental protocols. Additional research areas include dermatological applications where hydroxyzine’s antipruritic effects are examined in histamine-mediated responses. Pharmacokinetic studies benefit from this oral formulation when investigating absorption, distribution, and metabolism patterns. Cross-referencing with selective modulators and bioactive peptides provides comprehensive research frameworks for multi-target investigations.
Compound Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Hydroxyzine Hydrochloride 25mg |
| Molecular Formula | C₂₁H₂₇ClN₂O₂·2HCl |
| CAS Number | 2192-20-3 |
| Molecular Weight | 447.83 g/mol |
| Manufacturer | Dr. Reddy’s Laboratories |
| Form | Oral tablets |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Research Compliance
This product is supplied exclusively for in-vitro research applications and laboratory studies. Not intended for human consumption or therapeutic use. Researchers must maintain appropriate laboratory safety protocols and disposal procedures. All investigations should comply with institutional research guidelines and regulatory requirements for pharmaceutical research materials.
